Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked ...

For patients, a new diagnosis of diabetes can be overwhelming. It means not only managing blood sugar but also preventing serious future health complications such as diabetic retinal disease, a ...

November is Diabetes-related Eye Disease Awareness Month, and early detection and treatment of diabetes are key to reduce the risk for significant vision loss and blindness, according to Prevent ...

Please provide your email address to receive an email when new articles are posted on . The odds of developing dry eye disease were nearly four-times higher in patients with moderate to severe ...

Share on Pinterest New research links GLP-1 medications such as semaglutide and tirzepatide to a doubled risk of potentially blinding eye diseases. Javier Zayas Photography/Getty Images The most ...